Top Markets
#1 Decred Decred +8.72%
#2 Wibx Wibx +8.37%
#3 Status Status +7.35%
#4 SkyAI SkyAI +5.40%
#5 aelf aelf +5.26%
#6 MarsCoin MarsCoin +5.08%
#7 TRIA TRIA +4.98%
#8 Rei Rei +4.63%
#9 Wrapped Flare Wrapped Flare +4.46%
#10 DexNet DexNet +3.98%
Coin of the day
Decred Decred
Settings
Language
ENGLISH
Currency
USD
Theme
Metacare Co., Ltd. Metacare Co., Ltd.

Metacare Co., Ltd.

118000
Rank in Stocks #30541
Headquartered in Seoul, South Korea, Wooridul Huebrain Limited was founded in... Headquartered in Seoul, South Korea, Wooridul Huebrain Limited was founded in 2009. The company's operations span the medical, life and health, pharmaceutical, and storage industries. Its offerings include a range of medical equipment and devices, health-related apparatus, pharmaceutical products, and computer server solutions. The firm rebranded as Wooridul Huebrain Limited in April 2014, having previously operated under the name Wooridul Life Sciences Limited.
Share Price
$0.95356965
Market Cap
$16.38M
Change (1 day)
-0.58%
Change (1 year)
-58.64%
Country
KR
Trade Metacare Co., Ltd. (118000)

Category

Healthcare
Revenue for Metacare Co., Ltd. (118000)
Revenue in Aug 2026 TTM: 0
According to Metacare Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Metacare Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US